MOGAMULIZUMAB-KPKC (POTELIGEO) Nursing Considerations

What is the generic name?

MOGAMULIZUMAB-KPKC

What is the Trade Name for MOGAMULIZUMAB-KPKC?

POTELIGEO

What are the Indications for MOGAMULIZUMAB-KPKC?

• 1 INDICATIONS AND USAGE POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or S√©zary syndrome (SS) after at least one prior systemic therapy. POTELIGEO is a CC chemokine receptor type 4 (CCR4)-directed monoclonal antibody indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides or S√©zary syndrome after at least one prior systemic therapy ( 1 ).

References: https://open.fda.gov/